drugset / Trial / NCT00664859
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
NaSingle-groupOpen-labelTreatment
Summary
The current study is designed to test the long-term (12-month) safety and efficacy of LCP-AtorFen, a combination of atorvastatin and fenofibrate, in patients with dyslipidemia
Timeline
- Start
- 2007-10
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | Oral |
| Subject | Fenofibrate | Small molecule | — | Oral |